US8257041090 - Common Stock
SI-BONE INC
NASDAQ:SIBN (11/12/2024, 8:00:02 PM)
After market: 11.5 -4.13 (-26.42%)15.63
-0.29 (-1.82%)
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 344 full-time employees. The company went IPO on 2018-10-17. The firm specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The firm's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The firm's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
SI-BONE INC
471 El Camino Real, Suite 101
Santa Clara CALIFORNIA 95050
P: 14082070700
CEO: Jeffrey W. Dunn
Employees: 344
Website: https://si-bone.com/
Get insights into the top gainers and losers of Tuesday's after-hours session.
Expects to achieve positive Adjusted EBITDA in Fourth Quarter 2024...
The iFuse Bedrock Graniteā¢ system is a Breakthrough Device Designation technology that provides pelvic fixation and sacroiliac joint fusion, in conjunction...
SANTA CLARA, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,...
Here you can normally see the latest stock twits on SIBN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: